JPS5888316A - 傷治癒用組成物、その製法及び利用 - Google Patents

傷治癒用組成物、その製法及び利用

Info

Publication number: JPS5888316A
Authority: JP; Japan
Prior art keywords: medium; ointment; amniotic membrane; preparation; preparation according
Prior art date: 1981-11-05
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

JP57192628A

Other languages

English (en)

Japanese (ja)

Inventor

ウオ−ド・ペイジ・フオ−ク

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Johnson and Johnson

Original Assignee

Johnson and Johnson

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1981-11-05

Filing date

1982-11-04

Publication date

1983-05-26

1982-11-04 Application filed by Johnson and Johnson filed Critical Johnson and Johnson

1983-05-26 Publication of JPS5888316A publication Critical patent/JPS5888316A/ja

Status Pending legal-status Critical Current

Links

239000000203 mixture Substances 0.000 title claims description 19
238000004519 manufacturing process Methods 0.000 title claims description 10
210000001691 amnion Anatomy 0.000 claims description 36
239000002609 medium Substances 0.000 claims description 25
206010052428 Wound Diseases 0.000 claims description 21
208000027418 Wounds and injury Diseases 0.000 claims description 20
239000002674 ointment Substances 0.000 claims description 20
238000002360 preparation method Methods 0.000 claims description 18
239000001963 growth medium Substances 0.000 claims description 16
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 6
239000007788 liquid Substances 0.000 claims description 4
239000004480 active ingredient Substances 0.000 claims description 3
229910002092 carbon dioxide Inorganic materials 0.000 claims description 3
239000001569 carbon dioxide Substances 0.000 claims description 3
238000012258 culturing Methods 0.000 claims description 3
239000012188 paraffin wax Substances 0.000 claims description 3
230000001804 emulsifying effect Effects 0.000 claims description 2
238000001914 filtration Methods 0.000 claims description 2
239000003899 bactericide agent Substances 0.000 claims 2
230000000474 nursing effect Effects 0.000 claims 2
206010011224 Cough Diseases 0.000 claims 1
235000016623 Fragaria vesca Nutrition 0.000 claims 1
240000009088 Fragaria x ananassa Species 0.000 claims 1
235000011363 Fragaria x ananassa Nutrition 0.000 claims 1
241001494479 Pecora Species 0.000 claims 1
101150063503 RAI1 gene Proteins 0.000 claims 1
101100224844 Schizosaccharomyces pombe (strain 972 / ATCC 24843) din1 gene Proteins 0.000 claims 1
241000270708 Testudinidae Species 0.000 claims 1
239000007864 aqueous solution Substances 0.000 claims 1
239000003795 chemical substances by application Substances 0.000 claims 1
238000004587 chromatography analysis Methods 0.000 claims 1
238000009472 formulation Methods 0.000 claims 1
239000008311 hydrophilic ointment Substances 0.000 claims 1
238000000746 purification Methods 0.000 claims 1
210000004027 cell Anatomy 0.000 description 9
238000000034 method Methods 0.000 description 7
230000029663 wound healing Effects 0.000 description 6
239000000853 adhesive Substances 0.000 description 5
230000001070 adhesive effect Effects 0.000 description 5
239000010410 layer Substances 0.000 description 5
150000003839 salts Chemical class 0.000 description 5
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
208000025865 Ulcer Diseases 0.000 description 4
230000002745 absorbent Effects 0.000 description 4
239000002250 absorbent Substances 0.000 description 4
230000001737 promoting effect Effects 0.000 description 4
231100000397 ulcer Toxicity 0.000 description 4
239000002870 angiogenesis inducing agent Substances 0.000 description 3
230000002491 angiogenic effect Effects 0.000 description 3
210000001136 chorion Anatomy 0.000 description 3
210000004379 membrane Anatomy 0.000 description 3
239000012528 membrane Substances 0.000 description 3
239000000843 powder Substances 0.000 description 3
210000001519 tissue Anatomy 0.000 description 3
239000003104 tissue culture media Substances 0.000 description 3
208000008601 Polycythemia Diseases 0.000 description 2
241001474791 Proboscis Species 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
239000002390 adhesive tape Substances 0.000 description 2
239000012298 atmosphere Substances 0.000 description 2
230000001684 chronic effect Effects 0.000 description 2
239000006071 cream Substances 0.000 description 2
239000000645 desinfectant Substances 0.000 description 2
239000012153 distilled water Substances 0.000 description 2
239000000284 extract Substances 0.000 description 2
239000011521 glass Substances 0.000 description 2
230000035876 healing Effects 0.000 description 2
239000000463 material Substances 0.000 description 2
210000002966 serum Anatomy 0.000 description 2
235000017557 sodium bicarbonate Nutrition 0.000 description 2
229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
238000003860 storage Methods 0.000 description 2
UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
206010063560 Excessive granulation tissue Diseases 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
239000007995 HEPES buffer Substances 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
208000037581 Persistent Infection Diseases 0.000 description 1
OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
208000007536 Thrombosis Diseases 0.000 description 1
239000002253 acid Substances 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
239000012790 adhesive layer Substances 0.000 description 1
230000002411 adverse Effects 0.000 description 1
230000033115 angiogenesis Effects 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
230000002421 anti-septic effect Effects 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
238000003556 assay Methods 0.000 description 1
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
230000036770 blood supply Effects 0.000 description 1
210000004204 blood vessel Anatomy 0.000 description 1
229910052792 caesium Inorganic materials 0.000 description 1
TVFDJXOCXUVLDH-UHFFFAOYSA-N caesium atom Chemical compound [Cs] TVFDJXOCXUVLDH-UHFFFAOYSA-N 0.000 description 1
244000309466 calf Species 0.000 description 1
150000001720 carbohydrates Chemical class 0.000 description 1
235000014633 carbohydrates Nutrition 0.000 description 1
229910052799 carbon Inorganic materials 0.000 description 1
239000000969 carrier Substances 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
238000005119 centrifugation Methods 0.000 description 1
230000008859 change Effects 0.000 description 1
230000001055 chewing effect Effects 0.000 description 1
230000035606 childbirth Effects 0.000 description 1
239000000356 contaminant Substances 0.000 description 1
238000002316 cosmetic surgery Methods 0.000 description 1
210000003785 decidua Anatomy 0.000 description 1
238000011156 evaluation Methods 0.000 description 1
230000001605 fetal effect Effects 0.000 description 1
210000002950 fibroblast Anatomy 0.000 description 1
210000003953 foreskin Anatomy 0.000 description 1
238000004108 freeze drying Methods 0.000 description 1
FBPFZTCFMRRESA-GUCUJZIJSA-N galactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-GUCUJZIJSA-N 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
210000001126 granulation tissue Anatomy 0.000 description 1
238000003306 harvesting Methods 0.000 description 1
210000003128 head Anatomy 0.000 description 1
230000036541 health Effects 0.000 description 1
210000005260 human cell Anatomy 0.000 description 1
239000012678 infectious agent Substances 0.000 description 1
230000036512 infertility Effects 0.000 description 1
229910052500 inorganic mineral Inorganic materials 0.000 description 1
230000009545 invasion Effects 0.000 description 1
210000003127 knee Anatomy 0.000 description 1
230000007774 longterm Effects 0.000 description 1
210000004072 lung Anatomy 0.000 description 1
239000011159 matrix material Substances 0.000 description 1
235000010755 mineral Nutrition 0.000 description 1
239000011707 mineral Chemical class 0.000 description 1
239000002808 molecular sieve Substances 0.000 description 1
235000016709 nutrition Nutrition 0.000 description 1
230000035764 nutrition Effects 0.000 description 1
229910052760 oxygen Inorganic materials 0.000 description 1
239000001301 oxygen Substances 0.000 description 1
230000032696 parturition Effects 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
-1 phospho Chemical class 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
239000011148 porous material Substances 0.000 description 1
239000000047 product Substances 0.000 description 1
230000035755 proliferation Effects 0.000 description 1
230000005855 radiation Effects 0.000 description 1
230000004044 response Effects 0.000 description 1
229920006395 saturated elastomer Polymers 0.000 description 1
238000000926 separation method Methods 0.000 description 1
210000004894 snout Anatomy 0.000 description 1
URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
210000004872 soft tissue Anatomy 0.000 description 1
239000000243 solution Substances 0.000 description 1
238000005507 spraying Methods 0.000 description 1
229960005322 streptomycin Drugs 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
238000013268 sustained release Methods 0.000 description 1
239000012730 sustained-release form Substances 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Developmental Biology & Embryology (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Cell Biology (AREA)
Biotechnology (AREA)
General Chemical & Material Sciences (AREA)
Dermatology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pregnancy & Childbirth (AREA)
Reproductive Health (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Virology (AREA)
Zoology (AREA)
Epidemiology (AREA)
Materials For Medical Uses (AREA)
Medicinal Preparation (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

JP57192628A 1981-11-05 1982-11-04 傷治癒用組成物、その製法及び利用 Pending JPS5888316A (ja)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB8133375		1981-11-05
GB08133375A GB2110531B (en)	1981-11-05	1981-11-05	Wound healing composition prepared from amnion

Publications (1)

Publication Number	Publication Date
JPS5888316A true JPS5888316A (ja)	1983-05-26

Family

ID=10525651

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP57192628A Pending JPS5888316A (ja)	1981-11-05	1982-11-04	傷治癒用組成物、その製法及び利用

Country Status (7)

Country	Link
JP (1)	JPS5888316A (de)
AT (1)	ATA402782A (de)
AU (1)	AU9010382A (de)
DE (1)	DE3240909A1 (de)
GB (1)	GB2110531B (de)
NZ (1)	NZ202259A (de)
ZA (1)	ZA828111B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8708009D0 (en) *	1987-04-03	1987-05-07	Clayton Found Res	Injectable soft tissue augmentation materials
GB8803697D0 (en) *	1988-02-17	1988-03-16	Deltanine Research Ltd	Clinical developments using amniotic membrane cells
WO1991000098A1 (fr) *	1989-06-23	1991-01-10	Kishinevsky Selskokhozyaistvenny Institut Imeni M.V.Frunze	Preparation anti-inflammatoire et son procede d'obtention
EP0735135A3 (de) *	1995-03-31	1997-12-29	DIZG Deutsches Institüt für Zell- und Gewebeersatz gGmbH	Zellschichten und Transportsystem für Zellschichten
RU2156131C1 (ru) *	1996-06-21	2000-09-20	Беляев Юрий Евгеньевич	Полуфабрикат для получения основы лекарственного средства, основы лекарственного средства из этого полуфабриката (варианты) и лекарственное средство на этой основе (варианты)
DE19925549B4 (de) *	1999-06-04	2004-12-23	Lts Lohmann Therapie-Systeme Ag	Verfahren zur aseptischen Herstellung von Wundauflagen und Verwendung derselben
EP1549328A4 (de) *	2002-09-18	2009-07-08	Emiliano Ghinelli	Verwendung einer humanen schafhäutchen-zusammesentzung zur prophylaxe und behandlung von erkrankungen und zuständen des auges und der haut
WO2004033635A2 (en) *	2002-10-04	2004-04-22	Tissuetech, Inc.	Retinal pigment epithelial cell cultures on amniotic membrane and transplantation
CN103361301A (zh) *	2005-03-31	2013-10-23	斯丹姆涅恩有限公司	高度纯化来自羊膜的细胞群
GB0514567D0 (en) *	2005-07-15	2005-08-24	Univ Nottingham	Surgical membrane
US8871198B2 (en) *	2006-03-29	2014-10-28	Stemnion, Inc.	Methods related to wound healing
US20090004161A1 (en)	2007-06-26	2009-01-01	Palladino Linda O	Methods for treating pustular conditions of the skin
US20120121547A1 (en) *	2010-09-16	2012-05-17	Wagner Donald J	Methods and compositions for treating chronic wounds

1981
- 1981-11-05 GB GB08133375A patent/GB2110531B/en not_active Expired
1982
- 1982-10-21 NZ NZ202259A patent/NZ202259A/en unknown
- 1982-11-03 AU AU90103/82A patent/AU9010382A/en not_active Abandoned
- 1982-11-04 JP JP57192628A patent/JPS5888316A/ja active Pending
- 1982-11-04 ZA ZA828111A patent/ZA828111B/xx unknown
- 1982-11-04 AT AT0402782A patent/ATA402782A/de not_active IP Right Cessation
- 1982-11-05 DE DE19823240909 patent/DE3240909A1/de not_active Ceased

Also Published As

Publication number	Publication date
AU9010382A (en)	1983-05-12
GB2110531B (en)	1985-05-01
NZ202259A (en)	1985-07-31
ZA828111B (en)	1984-06-27
ATA402782A (de)	1985-06-15
DE3240909A1 (de)	1983-05-11
GB2110531A (en)	1983-06-22

Publication	Publication Date	Title
US4570629A (en)	1986-02-18	Hydrophilic biopolymeric copolyelectrolytes, and biodegradable wound dressing comprising same
CA2351341C (en)	2008-04-29	Collagen hemostatic foam
US4414202A (en)	1983-11-08	Composition for treatment of wounds
US7196054B1 (en)	2007-03-27	Methods for treating wound tissue and forming a supplemented fibrin matrix
US4778679A (en)	1988-10-18	Method and composition for treatment of wounds
JPH0636815B2 (ja)	1994-05-18	人工皮膜代用品としてのセルロース皮膜の製造方法
JPS5888316A (ja)	1983-05-26	傷治癒用組成物、その製法及び利用
CN109731130A (zh)	2019-05-10	一种低温生物3d打印技术制备水凝胶创面敷料的方法
JPH0549302B2 (de)	1993-07-23
KR20010042539A (ko)	2001-05-25	액체매체 속의 천연 콜라겐의 멸균 방법, 획득된 멸균천연 콜라겐, 그 것을 함유하는 조성물 및 용도
JP2002501525A (ja)	2002-01-15	火傷及び他の皮膚外傷の治療のための組成物及び手段
US5300306A (en)	1994-04-05	Tissue-equivalent membrane from bovine esophageal tissue
Gupta et al.	1991	Calcium alginate in the management of acute surgical wounds and abscesses
CZ277766B6 (en)	1993-04-14	Biologically active material and process for preparing thereof
CN108350420A (zh)	2018-07-31	培养细胞的方法
EP0034504B1 (de)	1986-04-23	Kombinationen für die Behandlung von Wunden
CN103083721B (zh)	2014-12-10	一种京尼平固定活化素b的人工皮肤移植物及制备方法
GB2146523A (en)	1985-04-24	Preparation for stimulating growth of blood vessels prepared from aminochorionic tissue and macrophages
CZ305405B6 (cs)	2015-09-02	Použití kombinace obsahující polymerové absorpční činidlo a nemetabolizovatelný cukr pro podporu buněčné rekonstrukce a/nebo buněčné diferenciace
Degernes et al.	1993	Soft-tissue wound management in avian patients
Ferguson et al.	1958	Preparation of cell cultures from human amnion
RU2158112C1 (ru)	2000-10-27	Способ кожной пластики
RU2841638C1 (ru)	2025-06-11	Способ лечения инфицированных ран у крупного рогатого скота
JPH0720873B2 (ja)	1995-03-08	創傷治癒剤
JPH0966097A (ja)	1997-03-11	皮膚欠損治療用被覆材